Find an expert

Dr Viana Vuvan is a titled Musculoskeletal Physiotherapist and Lecturer in Physiotherapy at The University of Queensland. Viana has a strong clinical background in musculoskeletal physiotherapy, with experience in managing a wide range of musculoskeletal and sports-related injuries. Viana has a special interest in the management of upper limb musculoskeletal disorders and enjoys sharing her experience with students in the undergraduate and postgraduate physiotherapy programs. Viana is an active member of the Sports Injury Rehabilitation and Prevention for Health (SIRPH) research unit and the Neck and Head Research Unit (NAHRU) at the University of Queensland.

Viana’s research is focused on improving the management of persistent musculoskeletal pain conditions, such as tendinopathies, and better understanding the mechanisms underlying their chronicity. Viana’s PhD research focused on lateral elbow tendinopathy and explored the factors contributing to pain, disability and chronicity within this group. Additionally, Viana has explored similar mechanisms in other tendinopathies, including Achilles, patellar tendinopathy, plantar fasciopathy, as well as in whiplash associated disorders. She has shared her research at numerous state-wide, national and international conferences, and has been awarded for her presentations at several conferences.

Associate Professor Chris Wall is the Director of Orthopaedics at Toowoomba Hospital. He is the Orthopaedic Co-Chair for the Australian and New Zealand Hip Fracture Registry (ANZHFR) and an Assistant Deputy Registry Clinical Director for the Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR). Associate Professor Wall's research interests include hip and knee replacement and orthopaedic trauma care.

Dr Michael Waller: is a biostatistician working on the Australian Longitudinal Study of Womens Health (ALSWH). He has previous experience working on cancer screening, and military health studies. His current research focus is using linked data sources to assess dementia rates and risk factors.

Dr Haolu Wang currently is a Medical Registrar and Basic Physician Trainee with the Royal Australasian College of Physicians - The Prince Charles Hospital and Redcliffe Hospital (Northside) Rotation. He is also an Honorary Research Fellow in the joint liver cancer research program of Frazer Institute, The University of Queensland and Gallipoli Medical Research Foundation. Dr Wang received his Bachelor of Medicine and Master of Surgery qualifications from Shanghai Jiao Tong University School of Medicine. He was awarded his PhD in Clinical Medicine from The University of Queensland. Dr Wang has worked as a Medical Officer at Renji Hospital, Shanghai Jiao Tong University School of Medicine and as a Researcher Officer at Frazer Institute, The University of Queensland.

Dr Wang has authored over 30 publications of clinical and translational research in liver diseases, including Hepatology, Theranostics, Int J Cancer, J Exp Clin Cancer Res and Pharmacol Ther. His standing in this field is reflected by awards from Australian National Health and Medical Research Council, United European Gastroenterology, European Microscopy Congress, The University of Queensland, Frazer Family Foundation and Shanghai Jiao Tong University.

Dr Ran Wang graduated with her PhD in 2015, and after undertaking a postdoc position in Scripps Research, USA returned to Australia in 2017. She is now a Senior Postdoctoral Researcher supported by the prestigious Bushell Postdoctoral Research Fellowship from the Gastroenterology Society of Australia. Dr Wang is interested to understand the nature of inflammation in gut and lung and investigate the local and systemic impacts of chronic gut inflammation. In addition to a growing track-record in the mucosal immunology field, she is also building an inter-disciplinary research profile in material science and nanotechnology for drug delivery and immune modulation. She is the Associate Editor of Frontier of Cellular and Infection Microbiology Journal since 2018.

MBBS MM (Sydney), PhD (Cambridge), FRACP, FCSANZ, FRCP (London), FESC

Consultant Cardiologist, Princess Alexandra Hospital, Brisbane.

Associate Professor, PAH-Southside Clinical Unit, Faculty of Medicine, The University of Queensland.

Research interests: clinical cardiology, cardiovascular imaging, genetics and indigenous health.

Dr David Ward is a Research Fellow in ageing and geriatric medicine at the Centre for Health Services Research, Faculty of Medicine. David is particularly interested in how people’s experiences, behaviours and health conditions can affect their chances of developing dementia as they grow older. A key component of his research is aimed at understanding the complex links between ageing, frailty and the brain.

David conducted his PhD at the Wicking Dementia Research and Education Centre, University of Tasmania, and graduated in 2015. This work centred on exploring modifiable (e.g. education level) and non-modifiable (e.g. genetics) risks for ageing-related cognitive decline within the Tasmanian Healthy Brain Project. David subsequently held postdoctoral research positions at Population Health Sciences, German Center for Neurodegenerative Diseases (DZNE, Bonn Germany)—where he investigated the viability of retinal biomarkers for cognitive functioning, among other topics—and Geriatric Medicine Research, Dalhousie University (Halifax Canada)—where he measured the relationships between frailty and the subsequent risks of mild cognitive impairment and dementia. After returning to Australia and prior to starting at The University of Queensland, David worked for two years as a Team Leader at the Ageing and Aged Care Unit, Australian Institute of Health and Welfare (Canberra Australia).

Since 2020 and resulting from David’s international postdoctoral positions, he has published three articles as first-author in world-leading journals: Neurology; the Journal of Neurology, Neurosurgery & Psychiatry; and Annals of Neurology. David has won an award from the Erica Bell Foundation for Excellence in Medical Research and has acted as a peer-review for 15 journals and as an External Grant Assessor for NHMRC Project Grants. David was one of four academic developers who created the Preventing Dementia MOOC (~100,000 completers and ranked 4.9/5.0 on Class Central) and in 2018 was invited to be a guest lecturer at the University of Bonn, Bonn International Graduate School. David is a member of the DEMON Network and is the current Chair of the Network's Frailty and Dementia Special Interest Group.

Prof Ward's research program has focused on adult acute services, including head and neck cancer management, critical care, and general dysphagia management. She conducts research into improving services, evaluating new models of care and new workforce models, digital service delivery models eg., telehealth, as well as clinical training models eg., simulation. Liz is also engaged in exploring the role and benefits of the clinician-researcher workforce within health services.

Prof Ward currently holds a joint position as the Director of the Centre for Functioning and Health (CFAHR), in Metro South Hospital and Health Service, Queensland Health, and, Conjoint Professor with the School of Health and Rehabilitation Sciences, The University of Queensland. Her research has a clinical focus with particular emphasis on projects designed to improve patient outcomes within health services. She has published extensively with over 450 publications to date and has a track record of competitive grant funding across a number of research fields. Liz has been awarded multiple UQ teaching awards and has supervised >40 students to successful completion of their research higher degree. In 2014 Liz was awarded the title of Fellow of Speech Pathology Australia in recognition of her contributions to the profession.

Brooke-Mai is a Senior Lecturer in Speech Pathology and a Certified Practicing Speech Pathologist. Her research interests include the rehabilitation of motor speech disorders, brain mechanisms underpinning speech recovery, and the application of telerehabilitation to improve access to speech pathology services.

Dr Lahann Wijenayake is the Head of Orthopaedic Surgery at The University of Queensland. He is a Brisbane based orthopaedic surgeon having obtained his FRACS and FAorthA through the Royal Australasian College of Surgeons. He is also an Associate Fellow of the Royal Australian College of Medical Administrators. Dr Wijenayake is a surgeon at the Queensland Children's Hospital. He has a keen interest in medical student teaching as well as research in the field of paediatric orthopaedics, orthopaedics, and medical student education.

I am a physiotherapist with a clinical specialty in the management of individuals with neurological conditions and vestibular disorders. I have a keen interest in examining how the body's balance systems, including the inner ear (vestibular system), eyes (ocular system), and sensory modalities (touch, proprioception), interact with the brain to optimize movement control, functionality, physical activity, and participation outcomes for individuals affected by neurological and vestibular pathologies. This includes conditions such as multiple sclerosis, cerebellar dysfunction, traumatic brain injury, stroke, Parkinson's disease, myasthenia gravis, motor neuron disease, concussion, Meniere's disease, vestibular migraines, acoustic neuromas, and age-related vestibular dysfunction. Additionally, I am interested in the influence of lifestyle choices on vestibular system functioning and integration, particularly how factors such as physical activity, community integration, sleep, and overall wellness affect both neurological and vestibular conditions, including Meniere's disease, vestibular migraines, and age-related vestibular dysfunction.

Wayne Wilson is an Associate Professor in the Discipline of Audiology at the School of Health and Rehabilitation Sciences, The University of Queensland (UQ). He holds a PhD and Post-graduate Diploma in audiology and a BSc(Hons) in auditory physiology. His research interests include listening and listening difficulties in children, the objective assessment of auditory function, and clinical competence in audiology. Wayne has published >110 papers in refereed scientific journals, 12 book chapters and 3 patents; has presented >325 papers at scientific conferences including 17 key-note/opening addresses; and has secured >35 competitive research grants totaling >AUD$4.2 million.

Mechanisms of drug-induced liver damage.

Liver disease has long been associated with the abuse and clinical use of drugs. My research interests focus on ethanol, perhaps the most commonly abused drug, and the widely used non-steroidal anti-inflammatory drugs (NSAIDS). Both NSAIDS and ethanol are widely tolerated but induce liver disease in a small number of individuals.

Research projects listed below investigate immunological and genetic phenomena associated with drug-induced liver disease.

• Does ethanol alter hepatic gene expression to cause liver damage?
• Is protein modification by ethanol metabolites involved in the aetiology of alcoholic tissue injury?
• Are proteins modified by reactive molecules formed during ethanol metabolism viable biomarkers of ethanol intake?

Dr. Ayaho Yamamoto is the Group Leader of Laboratory Science at the Children's Health and Environmental Program and is a research fellow in the field of Biomedical Science. Her research focuses on understanding the mechanistic links between environmental exposures and adverse respiratory outcomes. In particular, she focuses on the cellular responses following air pollution exposure and/or viral infection on human respiratory epithelium, and the age differences in immune defence mechanisms. Investigate on early intervention strategies with dietary antioxidants to improve respiratory health and reduce the risk of long-term chronic diseases.

Dr. Yamamoto has a Bachelor of Science in Environmental Health and Public Health; her research focused on childhood asthma. She has a Master of Science in Biomedical Science and Pharmacology; the research focus was to understand the mechanisms and to test new drugs for osteoporosis and chondrosarcomas metastasis. She has worked in a Uni-based start-up company for drug development.

Dr Jun Yan is a molecular biologist, currently working in the field of neurological diseases. Dr Yan's research interest is cell signal transduction pathways invoved in mechanisms of the disease development.

Dr Jun Yan completed her postgraduate study at The University of Queensland, after which she undertook a postdoctoral position in Experimental Oncology laboratory in Department of Patholody, UQ and worked on Ras / Raf signalling pathway. In 2001 she joined the Neuroimmunology Research group in Department of Medicine, UQ, and works on neurological diseases, including autoimmune disease multiple sclerosis (MS), ischaemic stroke and amyotrophic lateral sclerosis (ALS) . She has been investigating NF-kB signal transduction pathway in MS and ALS, and cell immune responese to ischaemic stroke.

Professor Ian Yang is a Thoracic Physician and Director of Thoracic Medicine at The Prince Charles Hospital, and Head of the PCH-Northside Clinical Unit, School of Clinical Medicine, Faculty of Medicine, The University of Queensland, Brisbane, Australia.

Dr. Akila Wijerathna-Yapa is an interdisciplinary Biotechnology scientist and Postdoctoral Research Fellow at the Frazer Institute, University of Queensland, with over 12 years of expertise spanning Biochemistry, Molecular Biology, and Bioinformatics. Holding a PhD in Biochemistry from The University of Western Australia, an MSc in Molecular Biology from The Hebrew University of Jerusalem, an MBA from the University of Staffordshire, and B.Sc. (Hons.) Sp. Biotechnology from The Wayamba University of Sri Lanka, he brings a rare combination of deep scientific expertise and strategic project management insight to the life sciences.

Dr. Wijerathna-Yapa's research is defined by his ability to integrate advanced technologies—including mass spectrometry-based proteomics, peptidomics, metabolomics, lipidomics, NMR spectroscopy, and transcriptomics—to unravel molecular complexities and translate multi-omics data into actionable insights. His work spans molecular biology, cell culture bioprocess optimisation, clinical biomarker discovery, and spatial biology, with postdoctoral experience at The University of Queensland and Dalhousie University, and collaborative partnerships with leading research institutions across Sri Lanka, China, Israel, Australia, and Canada.

With a strong foundation in advanced statistical data analysis and a proven track record in project management and scientific communication, Dr. Wijerathna-Yapa bridges the gap between scientific discovery and practical innovation. He has authored over 25 peer-reviewed publications and has been recognised with prestigious international awards including the Australian Government Global Talent Independent visa and fellowships from the Higher Education Academy (FHEA, UKPSF). He is passionate about leveraging interdisciplinary knowledge to drive transformative advancements in biotechnology and life sciences.